High Cardiometabolic Risk Burden Predicts Adverse Outcomes in Patients with MASLD-Related Hepatocellular Carcinoma
Gut and Liver · 15.07.2026 · 20 (4) · 655-664
DOI: 10.5009/gnl250591 ↗Kurz gefasst
Fachartikel in der Zeitschrift Gut and Liver, online erschienen am 06.05.2026. Verfasst von Yeonhong Do und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Institute for Digestive Research, Digestive Disease Center, Soonchunhyang University Seoul Hospital, Soonchunhyang U…. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Cardiometabolic Risk Factors, Fatty Liver. Die Arbeit nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Korea Health Industry Development Institute, Ministry of Health and Welfare, Soonchunhyang University.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine, Institute for Digestive Research, Digestive Disease Center, Soonchunhyang University Seoul Hospital, Soonchunhyang University College of Medicine, Seoul, Korea.
- Department of Internal Medicine, Soonchunhyang University Cheonan Hospital, Soonchunhyang University College of Medicine, Cheonan, Korea.
- Department of Internal Medicine, Soonchunhyang University Bucheon Hospital, Soonchunhyang University College of Medicine, Bucheon, Korea.
- Division of Gastroenterology and Hepatology, Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, Korea.
ORCID-Profile: Yeonhong Do, Young Hyeon Ahn, Young Chang, Jeong-Ju Yoo, Sae Hwan Lee, Soung Won Jeong, Sang Gyune Kim, Jae Young Jang, Young Seok Kim, Hong Soo Kim, Keungmo Yang, Tom Ryu
Förderung
- Korea Health Industry Development Institute
- Ministry of Health and Welfare
- Soonchunhyang University
Zitieren
APA
Do, Y., Ahn, Y. H., Chang, Y., Yoo, J. J., Lee, S. H., Jeong, S. W., Kim, S. G., Jang, J. Y., Kim, Y. S., Kim, H. S., Yang, K., & Ryu, T. (2026). High Cardiometabolic Risk Burden Predicts Adverse Outcomes in Patients with MASLD-Related Hepatocellular Carcinoma. Gut and Liver, 20(4), 655-664. https://doi.org/10.5009/gnl250591
Vancouver
Do Y, Ahn YH, Chang Y, Yoo JJ, Lee SH, Jeong SW, et al. High Cardiometabolic Risk Burden Predicts Adverse Outcomes in Patients with MASLD-Related Hepatocellular Carcinoma. Gut and Liver. 2026;20(4):655-664. doi:10.5009/gnl250591
BibTeX
@article{Do2026,
author = {Do, Yeonhong and Ahn, Young Hyeon and Chang, Young and Yoo, Jeong-Ju and Lee, Sae Hwan and Jeong, Soung Won and Kim, Sang Gyune and Jang, Jae Young and Kim, Young Seok and Kim, Hong Soo and Yang, Keungmo and Ryu, Tom},
title = {High Cardiometabolic Risk Burden Predicts Adverse Outcomes in Patients with MASLD-Related Hepatocellular Carcinoma},
journal = {Gut and Liver},
year = {2026},
volume = {20},
number = {4},
pages = {655--664},
doi = {10.5009/gnl250591}
}
EUVIMED